Abstract: Tufted angioma is a rare vascular tumor whose name derives from its histopathological appearance, characterized by tufts of capillaries within the dermis. Its etiology and pathogenesis are uncertain. Tufted angioma typically occurs during infancy or early childhood and displays various clinical patterns. It may present as a subtle stain-like area that later thickens as a large plaque, infi ltrated or dusky blue-purple lesion, or as an exophytic, fi rm, violaceous, cutaneous nodule. Medical treatment is not necessary for tufted angioma, given its benign nature and slow progression. Only clinical follow-up is therefore recommended.
INTRODUCTION
Tufted angioma (TA) is a rare vascular tumor commonly localized in the skin and subcutaneous tissues and characterized by slow angiomatous proliferation. Most cases are usually acquired in childhood, with a protracted course, but it can also manifest in adulthood, as the case reported in this article. TA presents clinically as a subtle stain-like area that later thickens, as a large, plaque-like, infi ltrated, red or dusky blue-purple lesion, or as an exophytic, fi rm, violaceous, cutaneous nodule. TA is solitary, but multifocal cases have been reported. 1 Histologically, both acquired and congenital TAs demonstrate vascular tufts of tightly packed capillaries, randomly dispersed throughout the dermis in a typical "cannonball distribution" with crescent spaces surrounding the vascular tufts and lymphatic-like spaces within the tumor stromal.
2 TA may persist unchanged or regress completely within a few years. 3 Outpatient medications may include topical steroids or oral NSAIDs for the treatment of painful episodes associated with tufted angioma. Systemic corticosteroids and non-selective beta-adrenergic antagonist like propranolol have been used with success in a limited number of patients with tufted angioma, although this indication is not formally approved by the US Food and Drug Administration.
We report a case of an adult-onset TA localized on the shoulder of a 47-year-old woman.
CASE REPORT
We report the case of a red, infi ltrated, solitary plaque measuring 9 cm in the major axis, which had appeared two months before consultation on the shoulder of a 47-year-old female patient (Figure 1 ). On palpation, the lesion was tender, fi xed on the superficial and deep tissues. No pain or itching was reported.
Histological examination showed a slightly acanthotic epidermis and large vascular lobules in the full-thickness dermis (Figures 2 and 3 ). Each lobule was composed of aggregates of endothelial cells concentrically whorled along a preexisting vascular plexus. Immunohistochemistry showed positivity for CD31 and CD34, and negativity for smooth muscle actin (Figures 4 and 5) .
A diagnosis of "Acquired Tufted Angioma" was made. Due to the benignity of this lesion and the frequent spontaneous regression of TA, no treatment was suggested.
DISCUSSION
TA is a benign vascular tumor, also called "Angioblastoma of Nakagawa". 4 The name "tufted angioma" was fi rst proposed by Wilson Jones in 1976. 5 A similar lesion had been previously described by MacMillan and Champion in 1971 as a progressive capillary hemangioma. 6 Until now only 157 cases have been reported in the English literature. 3 TAs usually affects children and young adults, but both congenital cases and late-onset cases have been also reported. Most series claim that 60-70% of TAs develop before the age of 5 years, and 25% of tumors appear before the age of 1 year. Less than 10% of TAs occur after the age of 50 years, and its onset in people older than 60-80 years is rare. 7 Cases seem to appear sporadically, although a family with several members affected has been reported. 8 TA is generally described as a dull red, brownred, or purple cutaneous patch or plaque with angiomatous appearance. The patch or plaque slowly enlarges for 5 months to 10 years, after which no further growth occurs. The diameter of the patches generally ranges from less than 1 cm to several centimeters. On palpation, TA often has a rubbery consistency and may be painful. Some lesions may resemble connective tissue abnormalities. Generally, this tumor is described as solitary. However, multifocal presentations have been reported, frequently localized in the dermis and rarely involving the subcutaneous tissue.
TAs have predilection for the neck, upper chest, back and shoulder, although cases on the head and extremities have also been described. 4 The lesion grows slowly and insidiously, and usually stops growing after some years with little tendency of spontaneous regression. 4 The differential diagnosis includes infantile hemangiomas, congenital hemangiomas, vascular malformations and, especially in adult-onset cases, kaposiform hemangioendothelioma or Kaposi's sarcoma.
No causes of TA have yet been established. Trauma does not appear to be a predisposing factor, although a report describes the development of a lesion of tufted angioma at the site of a previous arthropod bite.
Some authors have noted the development of TA within port-wine stains, others have postulated that high hormonal levels during pregnancy and puberty may induce the development of TAs. 2, 9 Occasionally, TA may be associated with the platelet-trapping syndrome or Kasabach-Merritt syndrome (KMS): in this setting, the presence of petechial and ecchymotic patches should alert the physician to the development of KMS. 10 TAs have a characteristic histology consisting of a proliferation of endothelial cells forming lobules in the middle and lower part of the dermis, and in subcutaneous fat, with a specifi c "cannon-ball" pattern. The aggregates of endothelial cells are concentrically whorled along a preexisting vascular plexus. 9 Some lobules bulge the walls of dilated thin-walled vascular structure, giving a semi-lunar appearance to the vessels: this aspect, in addition to the angiocentricity, prompted the name "Tufted Angioma". 5 Immunohistochemistry demonstrates that the cells in the capillary tufts are positive for CD31, CD34 and, rarely, for smooth muscle actin. 9 No specifi c laboratory study is useful in the diagnosis or treatment of TA. If the coexistence of Kasabach-Merritt syndrome is suspected, a complete blood cell count with a determination of the platelet count, prothrombin time and/or activated partial thromboplastin time and full disseminated intravascular coagulation profi le is indicated.
Medical treatment is not necessary for TAs, due to the benign nature and slow progression of these vascular tumors: only clinical observation is recommended. Some authors have suggested low-dose radiotherapy, surgical excision, pulse dye laser, highdose systemic steroids and subcutaneous injections of interferon-α.
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